Evidence map›Paper›PMID 40579996›Full record

ArticleJournal of psychopharmacology (Oxford, England)2025

Effects of initial nicotine exposure on cognition and nicotine reinforcement among non-smoking young adults with and without attention deficit hyperactivity disorder.

Maggie M Sweitzer, Julianna Lazzari, Jessica Lunsford-Avery, Francis Joseph McClernon, Scott H Kollins, Kenneth A Perkins, Matthew Engelhard

Abstract read
In one paragraph

Article in Journal of psychopharmacology (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Maggie M SweitzerDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0000-0002-5085-3752
Julianna LazzariDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.ORCID 0009-0001-4353-6214
Jessica Lunsford-AveryDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Francis Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Scott H KollinsDepartment of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC, USA.
Kenneth A PerkinsDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Matthew EngelhardDepartment of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA.

Funding

Neurobehavioral mechanisms linking childhood adversity to increased risk for smokingR01DA054972 · NIDA · DUKE UNIVERSITY · PI Maggie M Sweitzer · 2022 to 2026
$2.9M
Behavioral and genetic mechanisms of smoking risk in individuals with ADHDR01DA033080 · NIDA · DUKE UNIVERSITY · PI KOLLINS, SCOTT H · 2012 to 2016
$2.2M
Smoking/Nicotine Dependence in Attention Deficit Hyperactivity Disorder (ADHD)K24DA023464 · NIDA · DUKE UNIVERSITY · PI KOLLINS, SCOTT H · 2008 to 2018
$1.5M
Sleep Dysfunction and Neurocognitive Outcomes in Adolescent ADHDK23MH108704 · NIMH · DUKE UNIVERSITY · PI LUNSFORD-AVERY, JESSICA RUTH · 2016 to 2022
$837k
Targeting reward dysfunction as a mechanism to improve smoking cessationK23DA039294 · NIDA · DUKE UNIVERSITY · PI SWEITZER, MAGGIE M · 2016 to 2020
$817k
Sustainable Habits for Encouraging Even Teen Sleep (SHEETS): A Digital Intervention to Enhance Sleep Regularity and Psychiatric Health in AdolescentsR34MH128440 · NIMH · DUKE UNIVERSITY · PI DUKE, NAOMI N, LUNSFORD-AVERY, JESSICA RUTH · 2022 to 2024
$725k
Preschool Attention and Sleep Support (PASS): A Telehealth Intervention for Children at Risk for ADHDR34MH131994 · NIMH · DUKE UNIVERSITY · PI LUNSFORD-AVERY, JESSICA RUTH · 2023 to 2025
$688k
NIDA NIH HHS K23 DA039294NIDA NIH HHS K24 DA023464NIDA NIH HHS R01 DA033080NIDA NIH HHS R01 DA054972NIMH NIH HHS K23 MH108704NIMH NIH HHS R34 MH128440NIMH NIH HHS R34 MH131994
6 · The paper itself

Abstract

backgroundPeople with attention deficit hyperactivity disorder (ADHD) use nicotine products at higher rates than those without. Greater initial sensitivity to nicotine's cognitive effects may explain this association.

aimsThis study examined associations between cognitive effects of nicotine administration and subsequent preference for nicotine versus placebo among young adults naïve to nicotine with and without ADHD.

methodsParticipants ( RESULTS/OUTCOMES: Nicotine increased subjective concentration and alertness for participants with ADHD but not controls; improved concentration predicted greater nicotine preference. In both groups, nicotine decreased errors of omission but increased errors of commission on the CPT, which predicted increased and decreased nicotine preference, respectively, during high cognitive demand. During the non-demanding condition, increased errors of commission predicted lower nicotine preference only for controls. CONCLUSIONS/

interpretationPerceived cognitive enhancement by nicotine may serve as a mechanism of risk for continued use in individuals with ADHD experimenting with nicotine. These findings help to clarify mechanisms underlying ADHD/nicotine use comorbidity and underscore the importance of early prevention.Declaration of interest/Funding:This work was supported by the National Institutes of Health.

Indexed as

Attention Deficit Disorder with HyperactivityCognitionNicotineNicotinic AgonistsAdministration, IntranasalAdolescentAdultDose-Response Relationship, DrugFemaleHumansMaleNon-SmokersReinforcement, PsychologySelf AdministrationYoung AdultNicotineNicotinic Agonistsaddiction riskADHDattentioncognitionNicotine

Identifiers

PMID40579996
PMCPMC12355662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.